BR0103180A - Derivados do diazabiciclooctano e suas utilizações terapêuticas - Google Patents

Derivados do diazabiciclooctano e suas utilizações terapêuticas

Info

Publication number
BR0103180A
BR0103180A BR0103180-5A BR0103180A BR0103180A BR 0103180 A BR0103180 A BR 0103180A BR 0103180 A BR0103180 A BR 0103180A BR 0103180 A BR0103180 A BR 0103180A
Authority
BR
Brazil
Prior art keywords
alkyl
chem
formula
aryl
heteroaryl
Prior art date
Application number
BR0103180-5A
Other languages
English (en)
Inventor
Anton Franz Joseph Fliri
Randall James Gallaschun
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0103180A publication Critical patent/BR0103180A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção: "DERIVADOS DO DIAZABICICLOOCTANO E SUAS UTILIZAçõES TERAPêUTICAS". A presente invenção refere-se a derivados de diazabiciclooctano de fórmula (I): e sais farmaceuticamente aceitáveis dos mesmos, onde o grupo represente R^ 1^ e R^ 2^ são selecionados independentemente a partir de H, (C~ 1~-C~ 6~)alquila, (C~ 1~-C~ 6~)fluoroalquila, halogênio (por exemplo, F, CI, Br, I), ciano, nitro, O-(C~ 1~-C~ 6~)alquila, O-(C~ 1~-C~ 6~)fluoroalquila, -NHC(O)R^ 4^ e -OR^ 4^ onde R^ 4^ e R^ 5^ são selecionados independentemente a partir de H, (C~ 1~-C~ 6~)alquila, e anel arila de 5- a 7-membros, ou R^ 1^ e R^ 2^ juntamente com os átomos aos quais eles estão ligados, formam um anel carboxíclico de 5- ou 6-membros ou anel heterocíclico de 5- ou 6-membros; e R^ 3^ é selecionado a partir do grupo consistindo em H, (C~ 1~-C~ 6~) alquila, (CH~ 2~)~ m~ arila ou (CH~ 2~)~ m~ heteroarila onde m é um número inteiro de 1 a 4, cada grupo arila ou heteroarila opcionalmente substituído com CI, Br, CN, CF~ 3~, O-(C~ 1~-C~ 6~)alquila, (C~ 1~-C~ 6~)alquila, sulfonil(C~ 1~-C~ 6~)alquila, -CO(C~ 1~-C~ 6~)alquila, -CONH~ 2~, -CONH(C~ 1~-C~ 6~)alquila, -CON((C~ 1~-C~ 6~)alquila)~ 2~, ou CH(OH)(C~ 1~-C~ 6~) alquila. A invenção também refere-se a composições farmaceuticamente aceitáveis de um composto de fórmula (I), e métodos de utilização deles no tratamento de doenças, condições ou distúrbios do sistema nervoso central. Além disso, a presente invenção é também dirigida a processos para a preparação de compostos de fórmula (I) e intermediários úteis.
BR0103180-5A 2000-08-03 2001-08-01 Derivados do diazabiciclooctano e suas utilizações terapêuticas BR0103180A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22270600P 2000-08-03 2000-08-03

Publications (1)

Publication Number Publication Date
BR0103180A true BR0103180A (pt) 2002-03-26

Family

ID=22833344

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0103180-5A BR0103180A (pt) 2000-08-03 2001-08-01 Derivados do diazabiciclooctano e suas utilizações terapêuticas

Country Status (12)

Country Link
US (1) US6531468B2 (pt)
EP (1) EP1178047B1 (pt)
JP (1) JP3825657B2 (pt)
AT (1) ATE260281T1 (pt)
BR (1) BR0103180A (pt)
CA (1) CA2354605C (pt)
DE (1) DE60102106T2 (pt)
DK (1) DK1178047T3 (pt)
ES (1) ES2211738T3 (pt)
MX (1) MXPA01007955A (pt)
PT (1) PT1178047E (pt)
TR (1) TR200400510T4 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1640364A1 (en) * 2003-06-27 2006-03-29 Toray Fine Chemicals Co., Ltd. Process for producing nitrogenous heterocyclic compound
JP2008534650A (ja) 2005-04-04 2008-08-28 ノイロサーチ アクティーゼルスカブ 新規置換ジアザビシクロ誘導体及びモノアミン神経伝達物質再取り込み阻害剤としてのそれらの使用
CN101952278A (zh) * 2008-02-15 2011-01-19 弗·哈夫曼-拉罗切有限公司 3-烷基-哌嗪衍生物及其用途
ES2532858T3 (es) 2008-07-23 2015-04-01 Toray Industries, Inc. Agente terapéutico para insuficiencia renal crónica
NO2447254T3 (pt) 2009-06-26 2018-05-05
IN2015MN00002A (pt) 2012-07-09 2015-10-16 Lupin Ltd
WO2016054123A1 (en) * 2014-09-30 2016-04-07 Lightner Derek Methods of producing heteropolycycles via bis-epoxidation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951980A (en) * 1974-05-09 1976-04-20 Stanford Research Institute 3-Substituted-8-methyl-3,8-diazabicyclo[3.2.1]octanes
FR2531709A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa Diazabicyclooctanes, procede pour leur preparation et compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
JP2002088084A (ja) 2002-03-27
TR200400510T4 (tr) 2004-08-23
CA2354605C (en) 2006-05-30
EP1178047A1 (en) 2002-02-06
PT1178047E (pt) 2004-05-31
EP1178047B1 (en) 2004-02-25
CA2354605A1 (en) 2002-02-03
DE60102106T2 (de) 2004-07-15
DE60102106D1 (de) 2004-04-01
MXPA01007955A (es) 2002-08-06
US20020068748A1 (en) 2002-06-06
ES2211738T3 (es) 2004-07-16
DK1178047T3 (da) 2004-05-24
US6531468B2 (en) 2003-03-11
JP3825657B2 (ja) 2006-09-27
ATE260281T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
ES2171109A1 (es) Derivados de 4-fenil-piridina.
IS2293B (is) Arýl sambrædd asapólýsýklísk efnasambönd
BRPI0409110A (pt) derivados de 4-(4-heterociclilalcoxi)fenil-1-(heterociclil-carboni l)piridina e compostos relacionados como antagonistas de histamina h3 para o tratamento de doenças neurológicas tais como alzheimer
DK1104759T3 (da) Heteroarylphenylpyrazolforbindelser som antiinflammatoriske/analgetiske midler
MXPA01007940A (es) Derivados de azabicicloalcano y usos terapeuticos de los mismos.
AU626740B2 (en) Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments
BR0103180A (pt) Derivados do diazabiciclooctano e suas utilizações terapêuticas
BR0011127A (pt) Derivados de 4-fenil-pirimidina
HUT63159A (en) Process for producing tokoferol derivatives and pharmaceutical compositions comprising same as active ingredient
PT1083178E (pt) Tetra-hidroquinazolino-2, 4-dionas e suas utilizacoes terapeuticas
ATE388945T1 (de) Benzoxazolderivate und deren verwendung als adenosinrezeptorliganden
NO20033049D0 (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1
HUP0003856A2 (hu) 6-Pirrolidin-2-ilpirindin-származékok, eljárás előállításukra és gyógyászati alkalmazásuk
FI914219A0 (fi) 3-(1h-indazol-3-yl)-4-pyridinaminer, foerfarande och mellanprodukter foer deras framstaellning och deras anvaendning som laekemedel.
NO20020475L (no) 2-aminotetralinderivater for terapi av glaukom
DE69327077T2 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
ATE258934T1 (de) Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
DE69722630D1 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009.